title: Re: Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy.
authors.forename: J I
authors.initials: JI
authors.lastname: Mayordomo
authors.forename: F
authors.initials: F
authors.lastname: Rivera
authors.forename: M T
authors.initials: MT
authors.lastname: Diaz-Puente
authors.forename: P
authors.initials: P
authors.lastname: Lianes
authors.forename: H
authors.initials: H
authors.lastname: Cortes-Funes
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D005334:Fever / Q000150:complications; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors